Transfusion
-
Randomized Controlled Trial Multicenter Study
A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
Anemia may be an important factor contributing to an increased risk of bleeding, particularly in patients with thrombocytopenia. ⋯ This pilot study thus indicated that it would be feasible to enroll the required number of patients to enable the performance of a large RCT to investigate the effect of Hb on bleeding risk in thrombocytopenic patients.